Navigation Links
Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
Date:10/1/2009

ars. Takeda also recently re-acquired the rights to Actos in this market, providing the business with a strong product with which to enter the market.

Overall, the new subsidiaries will accelerate Takeda's expansion efforts for core products including Actos and reinforces Takeda's global operating infrastructure. The company will work toward the earliest possible approval and launch of new products in these regions. Takeda's presence in these seven new countries builds upon other expansions announced in 2009 including commercial operations in Spain, Portugal, Ireland, and Canada.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Takeda is enhancing its R&D pipeline by concentrating its management resources in the following selected core therapeutic areas: lifestyle-related diseases, oncology and urological diseases (including gynecology), central nervous system diseases (including bone and joint disorders), and gastroenterological diseases. For more information, please visit http://www.takeda.com/.

About Takeda Pharmaceuticals Mexico, S.A. de C.V.

    Name:           Takeda Pharmaceuticals Mexico, S.A. de C.V.
    Location:      Mexico city, Mexico
    Established:  October 2009

About Takeda Pharmaceuticals Nordics AB

    Name:           Takeda Pharmaceuticals Nordics AB
    Location:      Sweden
    Established:  October 2009

About Takeda Pharmaceuticals Benelux SPRL

    Name:           Takeda Pharmaceuticals Benelux SPRL
    Location:      Belgium
    Established:  October 2009

About Takeda Pharmac
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
2. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
3. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
4. Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
5. Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
6. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
7. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
10. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
11. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
(Date:11/25/2009)...NIONCITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abax...facturingpoint-of-carebloodanalysissystems,announc...officer,willpresentatthe21stAnnualPiperJaffrayHeal...m.ET.TheconferencewillbeheldattheNewYorkPalaceHote...velops,manufacturesandmarketsportablebloodanalysis...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3
...6 D-Pharm announced today that it,has submitted I...to the US,Food and Drug Administration (FDA), for ...acute ischemic stroke patients. D-Pharm plans to i...view of the IND and SPA. Recently,D-Pharm also obt...s Agency,(EMEA) on the development strategy for DP...
...ikely to Suffer from Lower Body Injuries , , CINC..., obese children are significantly more likely to ...and legs. The Cincinnati Children,s Hospital Medic...if different body parts are injured in obese child...ion strategies can be developed, was presented May...
Other Medicine Technology:D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3The Injured Obese Child: Let's Give Him Some Ankle Support 2The Injured Obese Child: Let's Give Him Some Ankle Support 3
(Date:11/26/2009)...le Dental (RTDental), a leading dental group pract... expansion of its services to include LUMINEERS by... , Durham, NC (PRWEB) ... that Dr. Doug Macmillan, an experienced LUMINEER...ced training seminar. RTDental’s ability to...
(Date:11/25/2009)...re-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ...toreventsinDecember: ,, ASHBriefing ,, ...ncipalinvestigatorswilldiscussdatapresentationssur...plemyeloma,asfeaturedatthe51stAmericanSocietyofHem...,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a....
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...of a collaboration between UCLA engineers and phys...10 million Americans who suffer from peripheral ar... the arteries, peripheral arterial disease, or PAD...d arteries reduce blood flow to the limbs. The con...se, heart attack and stroke, and its progression c...
(Date:11/25/2009)... to overlook needed care, study finds , ,...s depression can worsen her child,s asthma, U.S. r...of 262 black mothers and their children found that...ms had more frequent asthma symptoms, while childr...ess frequent asthma symptoms. , The Johns Hopki...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
...s been detected in Asia, the British government an...re sites for any evidence of bird flu. The dea...s, reservoirs and parks will be brought to the not... from the University of Hong Kong have detected a ...
...ptoms of schizophrenia can be relieved by music th... London conducted a study in 4 hospitals and found...ents when they were encouraged to express themselv...n people are fairly stable," said Dr Mike Crawford...
...today welcomed the Stern Review as a timely and au...mpact of climate change on the world’s human popul... now. Commissioned by the UK Government and p...ortant he has ever received. Dr Haikerwal sa...
...om umbilical cord blood stem cells for the first t...eed for animal experiments for drug testing. A...ize of a 1p coin, is just the initial phase of gen... association with experts from the U.S. The artifi...
...n's agency has launched the first online game in K... HIV and Aids. The game is named as "What woul...ough several different scenarios so that he import...Aids. Africa has the largest number of HIV inf...
...nfant’s risk of cot death or sudden infant death s...hat affect breathing and temperature control. // ...s who died of SIDS. The findings were published in...ocessing of the chemical called serotonin in the b...
Other Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2Health News:Artificial Liver from Cord Blood Stem cells 2Health News:Brain stem Defects associated with SIDS 2
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
Medicine Products: